Chiron's Informed Solution
Executive Summary
Chiron believes its technology for quantifying DNA and RNA positions it to create disease management packages for diagnosis, therapy and prophylaxis. Alliances, both to bring in new diagnostics and therapeutics as well as information components, arecrucial to Chiron's disease management goals. Ciba Corning, the largest piece of Chiron's $600 million diagnostics business, is expected to provide the marketing infrastructure and some of the systems skills required to make the vision a reality.